DOI: https://doi.org/10.18370/2309-4117.2018.44.8-14

Endometrial polyps: optimization of anti-inflammatory therapy

Т. Ф Татарчук, Н. В. Косей, О. В. Занько, Т. І. Юско

Abstract


The frequency of hyperproliferative pathology of endometrium is about 60–70% in the structure of gynecological pathology of postmenopausal women. Endometrial polyps are a fairly frequent gynecological pathology for women of all ages, but the overwhelming majority of them are diagnosed at the age of 40–60 years. According to a number of studies, the frequency of endometrial polyps is 39.2–69.3%, and the endometrial polyposis occupies the first place in the structure of intrauterine pathology in postmenopausal.

Given the important role of inflammation in the etiology of endometrial polyps and the risk of infectious complications in the postoperative period, there is a need for a comprehensive approach to the examination and treatment of this pathology. To date, ultrasound diagnostics and hysteroscopy are considered the standard for diagnosing endometrial polyps. However, the use of hysteroscopic technique in postmenopausal patients has a number of limitations, which are primarily associated with the possible occurrence of anesthetic and surgical complications. With age in the body, women experience atrophic changes in the genital area, which are often the cause of the formation of stenosis and obliteration of the cervical canal, which increases the risk of injury during his burying and can lead to the formation of a «false» course and even perforation of the uterus. This causes a more complicated postoperative period, which is characterized by a pain syndrome, the presence of subfebrile, hematometry, etc. In addition, given the growth in postmenopausal frequency of extragenital pathology and metabolic syndrome, during the surgical interventions and in the postoperative period, the risk of thrombotic complications increases.

The article presents the substantiation of the expediency of conducting anti-inflammatory therapy in the postoperative period in postmenopausal patients after hystero-rectoscopic removal of polyps. The risk of complications of inflammatory nature after hysteroscopy is quite high and is 3–10%. The expediency of using the combined treatment regimen of endometrial polyps in this patient population using the enzyme complex Distreptaza®, which reduces the severity and duration of the pain syndrome, reduces the risk of developing subfebrile and formation of hematometry.


Keywords


endometrial polyp; inflammation; anti-inflammatory therapy

References


Batiyan, T.S. The role of infection in the genesis of endometrial polyps in postmenopause. Thesis abstract for PhD degree. Moscow (2012).

Veropotvelyan, P.N., Narytnik, T.T., Veropotvelyan, N.P., Guzhevskaya, I.V. “Modern view on the pathogenesis of postmenopausal endometrial polyps.” Women’s Health 2 (2015): 19–24.

Herman, D.G. Optimization of the complex of treatment of endometrial polyps. Thesis abstract for PhD degree. Kyiv (2017): 22 p.

Gusev, D.V., Shakhlamova, M.N., Budanov, P. “Debatable issues in the diagnosis of endometrial pathology in postmenopausal women.” The Journal Of Scientific Articles “Health & Education Millennium” 15 (2013): 143–7.

Zaporozhan, V.N., Tatarchuk, T.F., Dubinina, V.G., Kosei, N.V. “Modern diagnostics and treatment of endometrial hyperplastic processes.” Reproductive endocrinology 1 (2012): 5–12.

Kalugina, L.V., Tatarchuk, T.F. “Endometrial polyps: is anti-relapse therapy necessary?” Reproductive endocrinology 2 (2013): 69–75.

Strizhakov, A.N., Davidov, A.I., Pashkov, V.M., Lebedev, V.A. Benign diseases of the uterus. Moscow. GEOTAR-Media (2011): 288 p.

Tatarchuk, T.F., Kalugina, L.V., Tutchenko, T.N. “Endometrial hyperplastic processes: what’s new?” Reproductive endocrinology 5 (2015): 7–13.

Fedorenko, V.P., Gulak, L.O. “Sexual-age indicators of morbidity.” Bulletin of the National Cancer Register of Ukraine. App. A (2015). Available from: [http://www.ncru.inf.ua/publications/bull_18/pdf/zahv.pdf].

Chaika, G.V., Yaremchuk, L.V., Karetna, A.O. “Optimization of treatment and rehabilitation of reproductive function of women with endometrial hyperplasia against the background of inflammatory diseases of the pelvic organs.” Bulletin of the Vinnytsia National Medical University 1 (2017): 302–5.

Antunes, A., Vassallo, J., Anderson, P. “Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: a comparison between benign and malignant polyps in postmenopausal patients.” Oncology Letters 7 (2014): 1944–50.

Indraccolo, U., Di Iorio, R., Matteo, M. “The pathogenesis of endometrial polyps: a systematic semi-quantitative review.” European Journal Of Gynaecological Oncology 34 (2013): 5–22.

Lee, S.C., Kaunitz, A.M., Sanchez-Ramos, L. “The oncogenic potential of endometrial polyps: a systematic review and meta-analysis.” American college of obstetrics and gynecology 5 (2010): 1197–205.

Nappi, L., Indraccolo, U., Sardo, A.D. “Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps?” The Journal Of Minimally Invasive Gynecology 16 (2009): 157–62.

Topcu, H.O., Erkaya, S., Guze, A.I. “Risk Factors For Endometrial Hyperplasia Concomitant Endometrial Polyps In Pre- And Post-Menopausal Women.” Asian Pacific Journal Of Cancer Prevention 15 (2014): 5423–5.

Tanos, V. Berry, K.E., Stavroulis, A. “The Management Of Polyps In Female Reproductive Organs.” International Journal Of Surgery 43 (2017): 7–16.

Fang, R., Chen, L., Shu, W., et al. “Barcoded sequencing reveals diverse intrauterine microbiomes in patients suffering with endometrial polyps.” / Am J Transl Res 8 (2016): 1581–92.


GOST Style Citations


1.           Батиян, Т.С. Роль инфекции в генезе полипов эндометрия в постменопаузе : автореферат. дисс. … к. мед. наук / Т.С. Батиян. – М., 2012.

2.           Веропотвелян, П.Н. Современный взгляд на патогенез полипов эндометрия в постменопаузе / П.Н. Веропотвелян, Т.Т. Нарытник, Н.П. Веропотвелян, И.В. Гужевская // Здоровье женщины . – 2015. – №2. – С. 19–24.

3.           Герман, Д.Г. Оптимізація комплексу лікування поліпів ендометрія : автореферат. дис. … к. мед. наук / Д.Г. Герман. – К., 2017. – 22 с.

4.           Гусев, Д.В. Дискуссионные вопросы диагностики патологии эндометрия у женщин в постменопаузе / Д.В. Гусев, М.Н. Шахламова, П. Буданов // The Journal Of Scientific Articles “Health & Education Millennium”. – 2013. – №15. – С. 143–147.

5. Запорожан, В.Н. Современная диагностика и лечение гиперпластических процессов эндометрия / В.Н. Запорожан, Т.Ф. Татарчук, В.Г. Дубинина, Н.В. Косей // Репродуктивная эндокринология. – 2012. – №1. – С. 5–12.

6.           Калугина, Л.В. Полипы эндометрия: нужна ли противорецидивная терапия? / Л.В. Калугина, Т.Ф. Татарчук // Репродуктивная эндокринология. – 2013. – №2. –С. 69–75.

7.           Стрижаков, А.Н., Давыдов, А.И., Пашков, В.М., Лебедев, В.А. Доброкачественные заболевания матки. – М.: ГЭОТАР-Медиа, 2011. – 288 с.

8.           Татарчук, Т.Ф. Гиперпластические процессы эндометрия: что нового? / Т.Ф. Татарчук, Л.В. Калугина, Т.Н. Тутченко //Репродуктивная эндокринология. – 2015. – №5. – С. 7–13.

9.           Федоренко, B.П. Статево-вікові показники захворюваності / B.П. Федоренко, Л.О. Гулак // Бюлетень Національного канцер-реєстру України. Додаток А. – 2015 р.

10. Чайка, Г.В. Оптимізація лікування та реабілітації репродуктивної функції жінок з гіперплазією ендометрія на тлі запальних захворювань органів малого тазу / Г.В. Чайка, Л.В. Яремчук, А.О. Каретна // Вісник Вінницького Національного медичного університету. – 2017. – №1. – С. 302–305.

11.         Antunes, A., Vassallo, J., Anderson, P. “Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps: a comparison between benign and malignant polyps in postmenopausal patients.” Oncology Letters 7 (2014): 1944–50.

12.         Indraccolo, U., Di Iorio, R., Matteo, M. “The pathogenesis of endometrial polyps: a systematic semi-quantitative review.” European Journal Of Gynaecological Oncology 34 (2013): 5–22.

13.         Lee, S.C., Kaunitz, A.M., Sanchez-Ramos, L. “The oncogenic potential of endometrial polyps: a systematic review and meta-analysis.” American college of obstetrics and gynecology 5 (2010): 1197–205.

14.         Nappi, L., Indraccolo, U., Sardo, A.D. “Are diabetes, hypertension, and obesity independent risk factors for endometrial polyps?” The Journal Of Minimally Invasive Gynecology 16 (2009): 157–62.

15.         Topcu, H.O., Erkaya, S., Guze, A.I. “Risk Factors For Endometrial Hyperplasia Concomitant Endometrial Polyps In Pre- And Post-Menopausal Women.” Asian Pacific Journal Of Cancer Prevention 15 (2014): 5423–5.

16.         Tanos, V. Berry, K.E., Stavroulis, A. “The Management Of Polyps In Female Reproductive Organs.” International Journal Of Surgery 43 (2017): 7–16.

17.         Fang, R., Chen, L., Shu, W., et al. “Barcoded sequencing reveals diverse intrauterine microbiomes in patients suffering with endometrial polyps.” / Am J Transl Res 8 (2016): 1581–92.





Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN 2411-1295 (Online), ISSN 2309-4117 (Print)